首页> 外文OA文献 >Antiviral activity of baicalein and quercetin against the japanese encephalitis virus
【2h】

Antiviral activity of baicalein and quercetin against the japanese encephalitis virus

机译:黄ical素和槲皮素对日本脑炎病毒的抗病毒活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Japanese encephalitis (JE), a mosquito-borne viral disease, is endemic to the entire east and southeast Asia, and some other parts of the world. Currently, there is no effective therapeutic available for JE; therefore, finding the effective antiviral agent against JEV replication is crucial. In the present study, the in vitro antiviral activity of baicalein and quercetin, two purportedly antiviral bioflavonoids, was evaluated against Japanese encephalitis virus (JEV) replication in Vero cells. Anti-JEV activities of these compounds were examined on different stages of JEV replication cycle. The effects of the compounds on virus replication were determined by foci forming unit reduction assay (FFURA) and quantitative RT-PCR. Baicalein showed potent antiviral activity with IC50 = 14.28 mu g/mL when it was introduced to the Vero cells after adsorption of JEV. Quercetin exhibited weak anti-JEV effects with IC50 = 212.1 mu g/mL when the JEV infected cells were treated with the compound after virus adsorption. However, baicalein exhibited significant effect against JEV adsorption with IC50 = 7.27 mu g/mL while quercetin did not show any anti-adsorption activity. Baicalein also exhibited direct extracellular virucidal activity on JEV with IC50 = 3.44 mu g/mL. However, results of quantitative RT-PCR experiments confirmed the findings from FFURA. This study demonstrated that baicalein should be considered as an appropriate candidate for further investigations, such as the study of molecular and cellular mechanism(s) of action and in vivo evaluation for the development of an effective antiviral compound against Japanese encephalitis virus.
机译:日本脑炎(JE)是一种由蚊子传播的病毒性疾病,在整个东亚和东南亚以及世界其他地区都非常流行。目前,尚无有效的治疗JE的方法。因此,找到有效的抗JEV复制的抗病毒药物至关重要。在本研究中,评估了黄ical素和槲皮素这两种据称是抗病毒生物类黄酮的体外抗病毒活性,以对抗Vero细胞中的日本脑炎病毒(JEV)复制。在JEV复制周期的不同阶段检查了这些化合物的抗JEV活性。通过病灶形成单位减少测定(FFURA)和定量RT-PCR确定化合物对病毒复制的影响。黄ical素在吸附JEV后引入Vero细胞时显示出有效的抗病毒活性,IC50 = 14.28μg / mL。当病毒吸附后用该化合物处理JEV感染的细胞时,槲皮素显示出较弱的抗JEV效果,IC50 = 212.1μg / mL。然而,黄ical素对JEV吸附表现出显着的影响,IC50 = 7.27μg / mL,而槲皮素则没有任何抗吸附活性。黄ical素还对JEV表现出直接的杀细胞活性,IC50 = 3.44μg / mL。但是,定量RT-PCR实验的结果证实了FFURA的发现。这项研究表明,黄e素应被认为是进一步研究的合适人选,例如研究分子和细胞的作用机制以及体内开发抗日本脑炎病毒的有效抗病毒化合物的体内评价。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号